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40
The role of NogoA in limiting axonal fiber growth and regeneration following neuronal 41 injury is well known (Delekate et al., 2011) . NogoA inhibits neurite outgrowth of 42 motoneurons (NOM) via Nogo66 and NiGΔ20 domains (GrandPre et al., 2000) . (Simonen et al., 2003) , suggesting the presence of other pathways. 3 In Amyotrophic Lateral Sclerosis (ALS) patients, overexpression of NogoA in 48 muscle was positively correlated with the loss of motor endplates, and as the presence 49 of NogoA in muscle cells increases, denervation of endplates also increases (Bruneteau 50 et al., 2015) . It has also been reported that patients whose NogoA was overexpressed 51 in muscle cells and who were diagnosed with lower motor neuron syndrome (LMNS) 52 also had a higher likelihood of progressing to ALS symptoms (Pradat et al., 2007) . In 53 a mouse, NogoA could be detected in the muscles of embryos at E15 and P1 stages, but 54 not in the muscles in adults (Wang et al., 2002) . Interestingly, a significant increase of 55 NogoA was found in the muscle fibers of SOD1 G86R mice and ALS patients (Dupuis 56 et al., Jokic et al., 2005) . NogoA-knockout in SOD1 G86R mice (G86R -/-57 /NogoA -/-) showed longer survival time and increased survival rate (Jokic et al., 2006) . Sol8-NogoA CM failed to exhibit neurite outgrowth (Figure 1-figure supplement 1 ). NogoA CM (Figure 1-figure supplement 1 Figure 3A) . Even in the 153 low glycolytic condition induced by glycolysis inhibitor 3PO ( Figure 3B ), in which p-
154
Cofilin-S3 was insignificant compared to the untreated group ( Figure 3C , lanes 1 vs.
155
3), ePgk1 still downregulated p-Cofilin-S3 ( Figure 3C, lanes 3 vs. 4) Cofilin-S3 ( Figure 3D ), suggesting ePgk1 promotes NOM independent of glycolysis. 
Two-dimensional (2D) SDS-PAGE and LC/MS-MS analyses
